Evidence map›Paper›PMID 33014186›Full record

ArticleDisease markers2020

Digital PCR for the Analysis of

Alexander Brik, Daniel G Weber, Swaantje Casjens, Peter Rozynek, Swetlana Meier, Thomas Behrens, Georgios Stamatis, Kaid Darwiche, Dirk Theegarten, Thomas Brüning and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Evaluate the Prognosis ofTechnology in cancer research & treatment
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alexander BrikInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.ORCID https://orcid.org/0000-0003-1994-0724
Daniel G WeberInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Swaantje CasjensInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Peter RozynekInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Swetlana MeierInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Thomas BehrensInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Georgios StamatisDepartment of Thoracic Surgery, University Medicine Essen, Essen 45239, Germany.
Kaid DarwicheDepartment of Interventional Pneumology, University Medicine Essen, Essen 45239, Germany.
Dirk TheegartenDepartment of Pathology, University Medicine Essen, Essen 45239, Germany.
Thomas BrüningInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Georg JohnenInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum 44789, Germany.
Institute for Prevention and Occupational Medicine · DEEssen University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

resultsThe results of the

conclusionThe results of the study show that dPCR is an accurate and reliable method for the determination of

Indexed as

DNA Copy Number VariationsAdenocarcinoma of LungAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleGene AmplificationHumansLung NeoplasmsMaleMiddle AgedPrognosisProto-Oncogene Proteins c-mycBiomarkers, TumorMYC protein, humanProto-Oncogene Proteins c-myc

Identifiers

PMID33014186
PMCPMC7525309
OpenAlexW3087088078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.